UFPT Q2 revenue +15% to $174.0M; gross margin expands; debt down YoY

Filed August 6, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 11, 2025 · ~2 min read

Key Changes

• high

  Q2 revenue rose 15.1% YoY to $174.0M with organic growth accelerating to 12.4% (vs. 4.9% in Q2 FY25), driven by Surfaces & Support, Cardiovascular, Infection Control, and Orthopedics segments.

  MD&A: Revenue verify on EDGAR →
• high

  Gross margin improved 50bp to 29.3% in Q2 from operating efficiencies and leveraging organic sales growth against fixed overhead, reversing prior-year compression from AJR labor onboarding costs.

  MD&A: Gross Margin verify on EDGAR →
• high

  Total debt declined $46.3M YoY to $117.3M at June 30, 2026, with weighted average interest rate falling to 5.0%; interest expense dropped to $1.7M in Q2 from $2.7M.

  MD&A: Liquidity verify on EDGAR →